Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines.

Front Immunol · 2022 · PMC9592994 · PMID 36304475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similar trend of reduction in the proportion of S2-reactive CD4 + cells was also observed in participants with type 2 diabetes after the first dose, although this difference did not reach statistical significance ( Supplementary Figure 8A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.